A 5-Year Survival Prediction Model for Chronic Heart Failure Patients Induced by Coronary Heart Disease with

Hui Guan1, Guo-Hua Dai2, Wu-Lin Gao2

  • 1First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong, China.

Insights

This study developed a 5-year survival model for coronary heart disease (CHD) induced chronic heart failure (CHF), identifying eight predictors and confirming traditional Chinese medicine (TCM) as a protective factor.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Traditional Chinese Medicine

Background:

  • Coronary heart disease (CHD) frequently leads to chronic heart failure (CHF).
  • Accurate 5-year survival prediction is crucial for managing CHF patients post-discharge.
  • Integrating traditional Chinese medicine (TCM) factors may improve predictive models.

Purpose of the Study:

  • To construct and validate a 5-year survival prediction model for CHD-induced CHF.
  • To identify key independent predictors of mortality in this patient population.
  • To assess the influence of TCM interventions on 5-year survival.

Main Methods:

  • A retrospective cohort study involving 424 patients from seven hospitals (2012-2017).
  • Patients were randomly assigned to training and verification sets.
  • Least absolute shrinkage selection operator regression and logistic regression were used for model development, with nomograms for visualization. Model performance was assessed using C-indices, calibration curves, and decision curves.

Main Results:

  • The final model included eight independent predictors of 5-year mortality.
  • The model demonstrated strong predictive performance with C-indices of 0.885 (training), 0.867 (bootstrap), and 0.835 (verification).
  • Discrimination, calibration, and clinical practicability were confirmed through ROC curve, calibration curve, and decision curve analyses.

Conclusions:

  • Eight independent factors significantly impact 5-year mortality in CHD-induced CHF patients.
  • The developed prediction model is credible and aids in identifying high-risk individuals for resource allocation.
  • TCM intervention emerged as a protective factor, supporting its integration into CHF management.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
85
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
203
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
68
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
58
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
104
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
78